Emerging Tools for Stroke Prevention in Atrial Fibrillation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26981569.
- Also identified by DOI 10.1016/j.ebiom.2016.01.017 and PMC identifier 4776061.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.
Medical subject headings
- Atrial Fibrillation
- Stroke